Cargando…
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
BACKGROUND: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devastating complication; the optimal prophylactic strategy remains unclear. METHODS: We performed a multicentre, retrospective analysis of patients with DLBCL with high risk for CNS relapse as defined by...
Autores principales: | Cheah, C Y, Herbert, K E, O'Rourke, K, Kennedy, G A, George, A, Fedele, P L, Gilbertson, M, Tan, S Y, Ritchie, D S, Opat, S S, Prince, H M, Dickinson, M, Burbury, K, Wolf, M, Januszewicz, E H, Tam, C S, Westerman, D A, Carney, D A, Harrison, S J, Seymour, J F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453849/ https://www.ncbi.nlm.nih.gov/pubmed/25072255 http://dx.doi.org/10.1038/bjc.2014.405 |
Ejemplares similares
-
Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
por: Cheah, C Y, et al.
Publicado: (2013) -
P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
por: Shaw, B., et al.
Publicado: (2022) -
Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019) -
Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023) -
Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)